D. Kühl-Habich

The risk of breast tumours and lifetime history of oral contraceptive use.

W. Braendle, M. Lewis, L. Heinemann, 2002 .

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

L. Heinemann, J. Dinger, D. Kühl-Habich, 2007, Contraception.

Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health.

T. Raff, M. Lewis, L. Heinemann, 2003, European journal of obstetrics, gynecology, and reproductive biology.

The differential risk of oral contraceptives: the impact of full exposure history.

W. Spitzer, K. Macrae, R. Bruppacher, 1999, Human reproduction.

Lifetime History of Oral Contraceptive Use and Development of Tumours of the Uterus and Ovary*

E. Garbe, W. Braendle, M. Lewis, 2002 .

Drug use and adverse event monitoring in German children.

M. Lewis, J. von Rosen, D. Kühl-Habich, 2009, International journal of clinical pharmacology and therapeutics.

Use of oral contraceptives and risk of cancer of the uterine corpus or ovary. Two case-control studies

T. Raff, W. Braendle, M. Lewis, 2003 .